Skip to main content
Erschienen in: BMC Psychiatry 1/2023

Open Access 01.12.2023 | Research

Positive associations between sex hormones, bone metabolism and cognitive impairment in Chinese oldest-old females

verfasst von: Long Feng, Lihua Bian, Chaoxue Ning, Pei Zhang, Yali Zhao, Zhitao Gao, Ping Ping, Shihui Fu

Erschienen in: BMC Psychiatry | Ausgabe 1/2023

Abstract

Purpose

With a rapid increase in older adults, progressive impairment in cognitive function has become an increasing concern owing to high social and economic burdens. The current study was designed to investigate the associations of sex hormones and bone metabolism with cognitive impairment (CI) in Chinese oldest-old females.

Methods

There were 396 oldest-old females from the China Hainan Oldest-old Cohort Study (CHOCS). Following standardized procedures, Mini Mental State Examination was effectively completed, and sex hormones and bone metabolism were assessed in these females.

Results

The median age of all females was 101 years (range: from 80 to 116). There were 340 females (86%) with CI. Participants with CI had significantly higher levels of age, progesterone, prolactin and estradiol than those without CI (P < 0.05 for all). Total type I collagen N-terminal elongation peptide [hazard ratio (HR): 1.018, 95%CI: 1.001–1.035] and prolactin (HR: 1.065, 95%CI: 1.005–1.129) levels were positively and significantly associated with CI (P < 0.05 for all).

Conclusions

Prolactin and total type I collagen N-terminal elongation peptide had positive associations with CI in Chinese oldest-old females. Thus, a balance in sex hormones and bone metabolism may have significant effects on cognitive function during the aging process.
Hinweise
Long Feng, Lihua Bian, Chaoxue Ning, Pei Zhang are the co-first authors.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CI
cognitive impairment
CHOCS
China Hainan Oldest-old Cohort Study
HR
hazard ratio
MMSE
Mini-Mental State Examination.

Introduction

Aging is associated with an impairment in cognitive function, including verbal and visual memory, executive function, and spatial ability [1]. The number of older people is estimated to increase from 524 million in 2010 to 1.5 billion in 2050 all over the world [2]. Approximately 4.6 million people are diagnosed with dementia each year, with a 2-fold increase in the disease prevalence every 20 years [3]. Therefore, with a rapid increase in older adults, progressive impairment in cognitive function has become an increasing concern owing to high social and economic burdens [4, 5].
Pre-clinical and clinical studies have demonstrated that older females have a higher prevalence of cognitive impairment (CI), which may be closely connected with sex hormones, especially after menopause [68]. Approximately 60% women has CI after menopause, and hormonal change plays important effects on cognitive function [9]. There are several hypotheses on the sex differences in CI, such as difference in brain volume, anatomy and metabolism [10, 11]. Furthermore, there are reduced bone mineral density as a result of aging and physical inactivity. Previous study has indicated that CI have significant relationships with bone mineral density and sex hormone levels in older females [12, 13]. The pathophysiology of osteoporosis may be also related to the occurrence of dementia [14]. The estrogen receptor regulator Raloxifene has been used for the treatment of osteoporosis and may have the ability to improve cognitive function [15]. However, the exact relationships between between sex hormones, bone metabolism and CI still have no clear understanding in Chinese oldest-old females.
Hainan Province is an area with high prevalence of longevity; in fact, it has the highest population density of oldest-old females in China. Oldest-old females may represent a prototype of human longevity and should be considered the best representative [16]. The China Hainan Oldest-old Cohort Study (CHOCS) provides a considerable population-based sample of oldest-old females [17, 18]. For the first time, the current study was designed to investigate the associations of sex hormones and bone metabolism with CI in Chinese oldest-old females. It was hypothesized that CI may be related to sex hormones and bone metabolism in this population.

Methods

According to the list of oldest-old adults provided by the Department of Civil Affairs of Hainan Province, household survey was conducted on 1863 participants in 18 cities and counties from June 2014 to December 2016. Inclusion criteria: (1) aged ≥ 80 years; (2) residing in Hainan province. Exclusion criteria: (1) male adults; (2) did not complete Mini-Mental State Examination (MMSE) and had missing sex hormones and bone metabolism. Finally, there were 396 oldest-old females aged ≥ 80 years included in this study. The current study was performed in accordance with the principles stated in the Declaration of Helsinki and received the approval from Ethics Committee of Hainan Hospital of Chinese People’s Liberation Army General Hospital (Sanya, Hainan; Number: 301HNLL-2016-01). Informed consent was obtained from all subjects and their legal guardians.
Following standardized procedures, the household survey method was used to collect basic information with interview questionnaires, physical examinations, and blood tests conducted by professional doctors and nurses who could communicate in the local language. No participants received vitamin D, exogenous steroids, or other treatments that could affect their sex hormones and bone metabolism. The primary indicator was MMSE. It is well known that cognitive function was measured using the MMSE [19]. The Georgia Centenarian Study has confirmed that education significantly affect the performance of MMSE [20]. The cutoff points for identifying CI had definite distinction for people who had different levels of education: illiteracy with 17 points, elementary school level with 20 points, and junior high school level with 24 points were identified as CI [21, 22].
Blood samples were collected and transported by trained nurses in chilled bio-transport container (4 °C) to our Central Laboratory within 4 h. Plasma levels of sex hormones and bone metabolism were analyzed with the enzymatic analyses (Roche Products Ltd, Basel, Switzerland) on a fully automatic biochemical autoanalyzer (Cobas c702; Roche Products Ltd, Basel, Switzerland). All analyses were carried out by qualified technicians who were blinded to clinical data.

Statistical analyses

Data were analyzed using the Statistical Package for Social Sciences Version 17 (Chicago, IL, USA). Data were described using means and standard deviations (continuous variables with normal distribution), medians and interquartile ranges (continuous variables with skewed distribution), and numbers and percentages (categorical variables). Characteristic comparison was performed between participants with and without CI using Student’s t-tests for continuous variables with normal distribution, Mann–Whitney U tests for continuous variables with skewed distribution, and Chi-square tests for categorical variables. Logistic regression analysis was applied to analyze the factors associated with CI adjusted by all variables in Table 1 except MMSE and education level. A two-tailed P < 0.05 was regarded as statistically significant.
Table 1
Characteristics of all participants with and without cognitive impairment
Characteristics
With cognitive
impairment
(n = 340)
Without cognitive
impairment
(n = 56)
X2 a
Z b
P
Age (year)
101 (91, 103)
92 (84, 102)
 
-3.246
0.001
Body mass index (kg/m2)
18 (16,21)
19 (17, 22)
 
-1.696
0.090
Education level, n (%)
  
3.607
 
0.307
Illiteracy
330(97.1)
55(98.2)
   
Primary school
1(0.3)
0(0)
   
High school
9(2.3)
1(1.8)
   
Race, n (%)
  
1.822
 
0.610
Han
303(89.1)
53(94.6)
   
Others
37(10.9)
3(5.4)
   
Diabetes
22(6.5)
5(8.9)
0.457
 
0.499
Coronary heart disease, n (%)
14(4.1)
3(5.4)
0.180
 
0.672
Total type I collagen n-terminal elongation peptide (ug/L)
69.0 (52.0, 90.0)
63.0 (50.3, 76.8)
 
-1.595
0.111
β-crossLaps (ng/ml)
0.34 (0.21, 0.52)
0.31 (0.17, 0.49)
 
-1.238
0.216
Osteocalcin (ng/ml)
28.9 (19.9, 39.4)
26.8 (18.3, 33.9)
 
-1.351
0.177
Parathyroid hormone (pg/ml)
43.4 (31.5, 56.2)
38.6 (28.5, 48.8)
 
-1.890
0.059
25-hydroxyvitamin-D3 (ng/ml)
22.3 (17.2, 27.9)
24.1 (19.8, 28.7)
 
-1.538
0.124
Phosphonium ion (mmol/L)
1.08 (0.97, 1.18)
1.05 (0.97, 1.19)
 
-0.425
0.671
Calcium ion (mmol/L)
2.45 (2.16, 2.31)
2.25 (2.18, 2.31)
 
-0.985
0.325
Progesterone (nmol/L)
0.43 (0.10, 0.89)
0.32 (0.10, 0.57)
 
-2.372
0.018
Prolactin (ug/L)
12.9 (10.3, 17.6)
10.8 (8.6, 14.4)
 
-3.341
0.001
Estradiol (pmol/L)
18.4 (18.4, 44.9)
18.4 (18.4, 29.8)
 
-2.537
0.011
Testosterone (nmol)
0.35 (0.15, 0.63)
0.35 (0.11, 0.73)
 
-0.175
0.861
Human chorionic gonadotropin (U/L)
2.44 (1.36, 4.00)
2.26 (1.17, 3.36)
 
-1.576
0.115
Luteinizing hormone (mlU/ml)
36.0(28.1, 45.8)
34.4(28.3, 44.2)
 
-0.992
0.357
Follicle stimulating hormone (IU/L)
80.8 (62.7, 100.8)
79.3 (63.1, 100.3)
 
-0.126
0.900
Mini Mental State Examination
8.5 (6.0, 12.0)
21.0 (19.0, 25.0)
 
-12.016
< 0.001
aChi-square tests; bMann-Whitney U tests

Results

The median age of all females was 101 years (range: from 80 to 116). There were 340 females (86%) with CI. Table 1 showed characteristic comparison between all participants with and without CI. Participants with CI had significantly higher levels of age, progesterone, prolactin and estradiol than those without CI (P < 0.05 for all). As shown in Table 2, total type I collagen N-terminal elongation peptide [hazard ratio (HR): 1.018, 95%CI: 1.001–1.035] and prolactin (HR: 1.065, 95%CI: 1.005–1.129) levels were positively and significantly associated with CI (P < 0.05 for all).
Table 2
Factors associated with cognitive impairment in Logistic regression analysis of Chinese oldest-old females
Factors
HR
95%CI
P
Age (year)
1.042
1.000—1.086
0.051
Body mass index (kg/m2)
0.991
0.909—1.081
0.839
Race, n (%)
2.038
0.604–6.876
0.251
Diabetes, n (%)
0.873
0.286–2.666
0.812
Coronary heart disease, n (%)
0.733
0.181–2.974
0.664
Total type I collagen N-terminal elongation peptide (ug/L)
1.018
1.001—1.035
0.038
β-crossLaps (ng/ml)
0.177
0.027—1.173
0.073
Osteocalcin (ng/ml)
0.981
0.949—1.015
0.269
Parathyroid hormone (pg/ml)
1.017
0.996—1.037
0.107
25-hydroxyvitamin-D3 (ng/ml)
0.988
0.946—1.031
0.578
Phosphonium ion (mmol/L)
2.033
0.377—10.965
0.409
Calcium ion (mmol/L)
2.421
0.090—65.096
0.598
Progesterone (nmol/L)
2.658
0.983—7.187
0.054
Prolactin (ug/L)
1.065
1.005—1.129
0.034
Estradiol (pmol/L)
1.004
0.989—1.020
0.590
Testosterone (nmol)
1.094
0.784—1.527
0.596
Human chorionic gonadotropin (U/L)
1.135
0.936—1.376
0.199
Luteinizing hormone (mlU/ml)
1.002
0.963—1.043
0.909
Follicle stimulating hormone (IU/L)
1.001
0.984—1.018
0.915
HR: hazard ratio; CI: confidence interval

Discussion

The current study provided epidemiological evidence that prolactin and total type I collagen N-terminal elongation peptide levels were positively and significantly associated with CI in Chinese oldest-old females. All the above results give us a clue that an impairment in cognitive function of oldest-old females may be contributed by the change in sex hormones and bone metabolism.
Sex hormones play important roles in the brain of ovariectomized rodent, suggesting that menopause causes the changed levels of circulating sex hormones, which may have a certain effect on the occurrence of dementia. The current results showed that prolactin levels were positively and significantly associated with CI in Chinese oldest-old females. The Henderson recent review has indicated similar results that prolactin may have deleterious effects on cognitive function in older females after menopause [23]. One large study of women not taking hormone therapy showed significant relationships of prolactin with both verbal memory and global cognition [24]. Besides, a cohort study of Japanese-American women has realized that the users of prolactin showed an impairment in cognitive function [25, 26]. However, prolactin have been reported to play protective effects on pathogenic or brain dysfunction in various cell and animal models, such as different stroke types, traumatic brain injury, and age-related neurodegenerative diseases [2729]. In a word, there exists definite associations between CI and prolactin, but they are very complex, especially in postmenopausal oldest-old females.
Bone has been established as an endocrine organ regulating energetic metabolism, insulin secretion, and cognitive function [3033]. Bone metabolism has been identified to affect cognitive function [30]. Besides, low bone mineral density is related to CI in community-dwelling adults [34]. Recent studies have confirmed that circulating biomarkers of bone metabolism may have clinical potential to predict worsening CI [35, 36]. It is well known that bone formation is represented by total type I collagen n-terminal elongation peptide. The current study found that total type I collagen n-terminal elongation peptide levels were positively and significantly associated with CI, suggesting that CI may have positive association with bone resorption. Thus, an improvement in bone health may have beneficial effects on cognitive function during the aging process [37, 38].
Over the past 20–30 years, issues related to aging, multimorbidity, and poly pharmacy have become a prominent problem in healthcare worldwide [39]. In a retrospective study of patients older than 65 years admitted from a home care facility, 66% used five or more medications, 46% used more than seven medications, and 21% used 10 or more medications [40]. The number of drugs per prescription and their age are susceptibility factors for drug drug interaction (DDI) and potential adverse reactions (ADR). The prevalence of DDI and ADR in older adults has been reported to be two to three times greater than that in younger ones [41]. Therefore, poly pharmacy may also contribute to an increase in prolactin levels. An increased risk in older adults may be related to impaired organ reserve capacity, common multiple organ dysfunction, and altered pharmacokinetics and pharmacodynamics [42].
The new contribution of this study was that the study population was very representative. In the long-lived oldest-old females in Hainan Island of China, prolactin and total type I collagen N-terminal elongation peptide were found to have positive associations with CI, which provides scientific basis for cognitive aging prevention and brain health care of older women. However, this study has one limitation: it is a cross-sectional study. No causal relationship can be determined by this study.

Conclusions

The current study demonstrated that prolactin and total type I collagen N-terminal elongation peptide had positive associations with CI. Thus, a balance in sex hormones and bone metabolism may have significant effects on cognitive function during the aging process.

Acknowledgements

We appreciate all the staff of CHCCS for their continued cooperation and contribution in field work.

Declarations

Competing interests

The authors declare no competing interests.
The current study was performed in accordance with the principles stated in the Declaration of Helsinki and received the approval from Ethics Committee of Hainan Hospital of Chinese People’s Liberation Army General Hospital (Sanya, Hainan; Number: 301HNLL-2016-01). Informed consent was obtained from all subjects and their legal guardians.
Not applicable.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Price L, Said K, Haaland KY. Age-associated memory impairment of logical memory and visual reproduction. J Clin Exp Neuropsychol. 2004;26(4):531–8.PubMed Price L, Said K, Haaland KY. Age-associated memory impairment of logical memory and visual reproduction. J Clin Exp Neuropsychol. 2004;26(4):531–8.PubMed
2.
Zurück zum Zitat Tarry-Adkins JL, Ozanne SE. Nutrition in early life and age-associated diseases. Ageing Res Rev. 2017;39:96–105.PubMed Tarry-Adkins JL, Ozanne SE. Nutrition in early life and age-associated diseases. Ageing Res Rev. 2017;39:96–105.PubMed
3.
Zurück zum Zitat Yaffe K, Browner W, Cauley J, et al. Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc. 1999;47:1176–82.PubMed Yaffe K, Browner W, Cauley J, et al. Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc. 1999;47:1176–82.PubMed
4.
Zurück zum Zitat Blazer DG, Yaffe K, Karlawish J. Cognitive aging: a report from the Institute of Medicine. JAMA. 2015;313(21):2121–2.PubMed Blazer DG, Yaffe K, Karlawish J. Cognitive aging: a report from the Institute of Medicine. JAMA. 2015;313(21):2121–2.PubMed
5.
Zurück zum Zitat Barnes LL, Bennett DA. Alzheimer’s disease in African Americans: risk factors and challenges for the future. Health Aff. 2014;33(4):580–6. Barnes LL, Bennett DA. Alzheimer’s disease in African Americans: risk factors and challenges for the future. Health Aff. 2014;33(4):580–6.
6.
Zurück zum Zitat Dye RV, Miller KJ, Singer EJ et al. Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis. 2012;258454. Dye RV, Miller KJ, Singer EJ et al. Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis. 2012;258454.
7.
Zurück zum Zitat Phung TK, Waltoft BL, Laursen TM, et al. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement Geriatr Cogn Disord. 2010;30:43–50.PubMed Phung TK, Waltoft BL, Laursen TM, et al. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement Geriatr Cogn Disord. 2010;30:43–50.PubMed
8.
Zurück zum Zitat Koolschijn PC, Crone EA. Sex differences and structural brain maturation from childhood to early adulthood. Dev Cogn Neurosci. 2013;5:106–18.PubMedPubMedCentral Koolschijn PC, Crone EA. Sex differences and structural brain maturation from childhood to early adulthood. Dev Cogn Neurosci. 2013;5:106–18.PubMedPubMedCentral
9.
Zurück zum Zitat Mitchell ES, Woods NF. Cognitive symptoms during the menopausal transition and early postmenopause. Climacteric. 2001;14(2):252–61. Mitchell ES, Woods NF. Cognitive symptoms during the menopausal transition and early postmenopause. Climacteric. 2001;14(2):252–61.
10.
Zurück zum Zitat Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med. 2013;19:197–209.PubMedPubMedCentral Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med. 2013;19:197–209.PubMedPubMedCentral
11.
Zurück zum Zitat Carter CL, Resnick EM, Mallampalli M, et al. Sex and gender differences in Alzheimer’s disease: recommendations for future research. J Womens Health. 2012;21:1018–23. Carter CL, Resnick EM, Mallampalli M, et al. Sex and gender differences in Alzheimer’s disease: recommendations for future research. J Womens Health. 2012;21:1018–23.
12.
Zurück zum Zitat Zhou R, Deng J, Zhang M, et al. Association between bone mineral density and the risk of Alzheimer’s disease. J Alzheimers Dis. 2011;24:101–8.PubMed Zhou R, Deng J, Zhang M, et al. Association between bone mineral density and the risk of Alzheimer’s disease. J Alzheimers Dis. 2011;24:101–8.PubMed
13.
Zurück zum Zitat Schrager S. Epidemiology of osteoporosis in women with cognitive impairment. Ment Retard. 2006;44:203–11.PubMed Schrager S. Epidemiology of osteoporosis in women with cognitive impairment. Ment Retard. 2006;44:203–11.PubMed
14.
Zurück zum Zitat Laudisio A, Fontana DO, Rivera C, et al. Bone mineral density and cognitive decline in elderly women: results from the InCHIANTI Study. Calcif Tissue Int. 2016;98(5):479–88.PubMed Laudisio A, Fontana DO, Rivera C, et al. Bone mineral density and cognitive decline in elderly women: results from the InCHIANTI Study. Calcif Tissue Int. 2016;98(5):479–88.PubMed
15.
Zurück zum Zitat Yang ZD, Yu J, Zhang Q. Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials. Maturitas. 2013;75:341–8.PubMed Yang ZD, Yu J, Zhang Q. Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials. Maturitas. 2013;75:341–8.PubMed
16.
Zurück zum Zitat Fu S, Yu H, Li Y, et al. Multiple measures of mineral metabolism were associated with renal function in chinese centenarians: a cross-sectional study. Front Med. 2020;7:120. Fu S, Yu H, Li Y, et al. Multiple measures of mineral metabolism were associated with renal function in chinese centenarians: a cross-sectional study. Front Med. 2020;7:120.
17.
Zurück zum Zitat Fu S, Yao Y, Lv F, et al. Associations of immunological factors with metabolic syndrome and its characteristic elements in chinese centenarians. J Transl Med. 2018;16(1):315.PubMedPubMedCentral Fu S, Yao Y, Lv F, et al. Associations of immunological factors with metabolic syndrome and its characteristic elements in chinese centenarians. J Transl Med. 2018;16(1):315.PubMedPubMedCentral
18.
Zurück zum Zitat Fu S, Hu J, Chen X, et al. Mutant single nucleotide polymorphism rs189037 in ataxia-telangiectasia mutated gene is significantly associated with ventricular wall thickness and human lifespan. Front Cardiovasc Med. 2021;8:658908.PubMedPubMedCentral Fu S, Hu J, Chen X, et al. Mutant single nucleotide polymorphism rs189037 in ataxia-telangiectasia mutated gene is significantly associated with ventricular wall thickness and human lifespan. Front Cardiovasc Med. 2021;8:658908.PubMedPubMedCentral
19.
Zurück zum Zitat Ibrahim NM, Shohaimi S, Chong HT, et al. Validation study of the mini-mental state examination in a malay-speaking elderly population in Malaysia. Dement Geriatr Cogn Disord. 2009;27:247e53. Ibrahim NM, Shohaimi S, Chong HT, et al. Validation study of the mini-mental state examination in a malay-speaking elderly population in Malaysia. Dement Geriatr Cogn Disord. 2009;27:247e53.
20.
Zurück zum Zitat Xiu S, Zheng Z, Guan S, et al. Serum uric acid and impaired cognitive function in community-dwelling elderly in Beijing. Neurosci Lett. 2017;637:182e7. Xiu S, Zheng Z, Guan S, et al. Serum uric acid and impaired cognitive function in community-dwelling elderly in Beijing. Neurosci Lett. 2017;637:182e7.
21.
Zurück zum Zitat Rabins P, Schwartz S, Tschanz JA, et al. Risk factors for severe dementia from a population-based sample of incident Alzheimer’s disease: the Cache County Dementia Progression Study. Alzheimers Dement. 2011;7:356. Rabins P, Schwartz S, Tschanz JA, et al. Risk factors for severe dementia from a population-based sample of incident Alzheimer’s disease: the Cache County Dementia Progression Study. Alzheimers Dement. 2011;7:356.
22.
Zurück zum Zitat Kliegel M, Zimprich D, Rott C. Life-long intellectual activities mediate the predictive effect of early education on cognitive impairment in centenarians: a retrospective study. Aging Ment Health. 2004;8:430e7. Kliegel M, Zimprich D, Rott C. Life-long intellectual activities mediate the predictive effect of early education on cognitive impairment in centenarians: a retrospective study. Aging Ment Health. 2004;8:430e7.
24.
Zurück zum Zitat Henderson VW, St. John JA, Hodis HN, et al. Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci U S A. 2013;110:20290–5.PubMedPubMedCentral Henderson VW, St. John JA, Hodis HN, et al. Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci U S A. 2013;110:20290–5.PubMedPubMedCentral
25.
Zurück zum Zitat Rice MM, Graves AB, McCurry SM, et al. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older japanese american women: the Kame Project. Arch Intern Med. 2000;160:1641–9.PubMed Rice MM, Graves AB, McCurry SM, et al. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older japanese american women: the Kame Project. Arch Intern Med. 2000;160:1641–9.PubMed
26.
Zurück zum Zitat de Wit H, Schmitt L, Purdy R, et al. Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology. 2001;26:697–710.PubMed de Wit H, Schmitt L, Purdy R, et al. Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology. 2001;26:697–710.PubMed
27.
Zurück zum Zitat Jiang N, Chopp M, Stein D, et al. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 1996;735:101–7.PubMed Jiang N, Chopp M, Stein D, et al. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 1996;735:101–7.PubMed
28.
Zurück zum Zitat Roof RL, Hoffman SW, Stein DG. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol. 1997;31:1–11.PubMed Roof RL, Hoffman SW, Stein DG. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol. 1997;31:1–11.PubMed
29.
Zurück zum Zitat Wali B, Sayeed I, Stein DG. Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor Neurol Neurosci. 2011;29:61–71.PubMed Wali B, Sayeed I, Stein DG. Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor Neurol Neurosci. 2011;29:61–71.PubMed
30.
Zurück zum Zitat Obri A, Khrimian L, Karsenty G, et al. Osteocalcin in the brain: from embryonic development to age-related decline in cognition. Nat Reviews Endocrinol. 2018;14(3):174. Obri A, Khrimian L, Karsenty G, et al. Osteocalcin in the brain: from embryonic development to age-related decline in cognition. Nat Reviews Endocrinol. 2018;14(3):174.
31.
Zurück zum Zitat Oury F, Khrimian L, Denny CA, et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell. 2013;155:228–41.PubMed Oury F, Khrimian L, Denny CA, et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell. 2013;155:228–41.PubMed
32.
Zurück zum Zitat Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456–69.PubMedPubMedCentral Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456–69.PubMedPubMedCentral
33.
Zurück zum Zitat Ferron M, Hinoi E, Karsenty G, et al. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA. 2008;105:5266–70.PubMedPubMedCentral Ferron M, Hinoi E, Karsenty G, et al. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA. 2008;105:5266–70.PubMedPubMedCentral
34.
Zurück zum Zitat Kang HG, Park HY, Ryu HU, et al. Bone mineral loss and cognitive impairment: the PRESENT Project. Medicine. 2018;97(41):e12755.PubMedPubMedCentral Kang HG, Park HY, Ryu HU, et al. Bone mineral loss and cognitive impairment: the PRESENT Project. Medicine. 2018;97(41):e12755.PubMedPubMedCentral
35.
Zurück zum Zitat Ross RD, Shah RC, Leurgans S, et al. Circulating Dkk1 and TRAIL are associated with cognitive decline in community-dwelling older adults with cognitive concerns. J Gerontol A Biol Sci Med Sci. 2018;73(12):1688–94.PubMedPubMedCentral Ross RD, Shah RC, Leurgans S, et al. Circulating Dkk1 and TRAIL are associated with cognitive decline in community-dwelling older adults with cognitive concerns. J Gerontol A Biol Sci Med Sci. 2018;73(12):1688–94.PubMedPubMedCentral
36.
Zurück zum Zitat Lui LY, Stone K, Cauley JA, et al. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc. 2003;51:38–43.PubMed Lui LY, Stone K, Cauley JA, et al. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc. 2003;51:38–43.PubMed
37.
Zurück zum Zitat Bradburn S, McPhee JS, Bagley L, et al. Association between osteocalcin and cognitive performance in healthy older adults. Age Ageing. 2016;45:844–9.PubMedPubMedCentral Bradburn S, McPhee JS, Bagley L, et al. Association between osteocalcin and cognitive performance in healthy older adults. Age Ageing. 2016;45:844–9.PubMedPubMedCentral
38.
Zurück zum Zitat Hsu CL, Nagamatsu LS, Davis JC, et al. Examining the relationship between specific cognitive processes and falls risk in older adults: a systematic review. Osteoporos Int. 2012;23:2409–24.PubMedPubMedCentral Hsu CL, Nagamatsu LS, Davis JC, et al. Examining the relationship between specific cognitive processes and falls risk in older adults: a systematic review. Osteoporos Int. 2012;23:2409–24.PubMedPubMedCentral
39.
Zurück zum Zitat Admassie E, Melese T, Mequanent W, Hailu W, Srikanth BA. Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital, North West Ethiopia. J Adv Pharm Technol Res. 2013;4(4):183–9.PubMedPubMedCentral Admassie E, Melese T, Mequanent W, Hailu W, Srikanth BA. Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital, North West Ethiopia. J Adv Pharm Technol Res. 2013;4(4):183–9.PubMedPubMedCentral
40.
Zurück zum Zitat Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci. 2000;55(10):M554–9.PubMed Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci. 2000;55(10):M554–9.PubMed
41.
Zurück zum Zitat Nolan L, O’Malley K. Prescribing for the elderly. Part 1: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1988;36:142–49.PubMed Nolan L, O’Malley K. Prescribing for the elderly. Part 1: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1988;36:142–49.PubMed
42.
Zurück zum Zitat Gaeta T, Fiorini M, Ender K, Bove J, Diaz J. Potential drug-drug interactions in elderly patients presenting with syncope. J Emerg Med. 2002;2:159–62. Gaeta T, Fiorini M, Ender K, Bove J, Diaz J. Potential drug-drug interactions in elderly patients presenting with syncope. J Emerg Med. 2002;2:159–62.
Metadaten
Titel
Positive associations between sex hormones, bone metabolism and cognitive impairment in Chinese oldest-old females
verfasst von
Long Feng
Lihua Bian
Chaoxue Ning
Pei Zhang
Yali Zhao
Zhitao Gao
Ping Ping
Shihui Fu
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Psychiatry / Ausgabe 1/2023
Elektronische ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-023-04957-9

Weitere Artikel der Ausgabe 1/2023

BMC Psychiatry 1/2023 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.